Efficacy of a New Behavioral Treatment for Premature Ejaculation Using a Masturbation Aid Device: Star-Stop 3.0
NCT03304808 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2018-07-09
Summary
The present study included 57 patients ≥18 years who met diagnostic criteria for PE including intravaginal ejaculatory latency time (IELT) of ≤2 minutes and had a Premature Ejaculation Diagnostic Tool (PEDT) score ≥11.
Subjects were randomized to an experimental group that used the device with exercise programme (n=18) a first control group that only used the exercise programme (n=17) and a wait-list control group (n=22).
As a main outcome measure used stopwatch-measured average IELT, Premature Ejaculation Profile (PEP), and the Golombok-Rust Inventory of Sexual Satisfaction (GRISS).
Conditions
- Premature Ejaculation
- Cognitive-Behavior Treatment
- Masturbation Aid Device
Interventions
- DEVICE
-
Exercise Programme +device+ lubricant
A first line treatment for the PE of a new 7 weeks exercise programme to control male orgasm using a masturbation aid device in a variation of the classical stop-start technique first introduced by Semans in 1956. Four exercise: 1. Exercise of Masturbation that intends to raise awareness of the ejaculatory response and identify the tension on the muscles of the genital area . 2. Star and Stop to identify the tension and try to reduce this tension, on the pelvic floor muscles pay special attention to the anal sphincter. 3. Delay the ejaculatory response on four different occasions, by loosening the tension in the genital area and relaxing the anal sphincter not stop masturbating 4. Practice the ability to delay ejaculation as in previous exercises, but this time performing hip movements similar to penetration not stop masturbating
- BEHAVIORAL
-
Exercise Programme + lubricant
A first line treatment for the PE of a new 7 weeks exercise programme to control male orgasm using a masturbation aid device in a variation of the classical stop-start technique first introduced by Semans in 1956. Four exercise: 1. Exercise of Masturbation that intends to raise awareness of the ejaculatory response and identify the tension on the muscles of the genital area . 2. Star and Stop to identify the tension and try to reduce this tension, on the pelvic floor muscles pay special attention to the anal sphincter. 3. Delay the ejaculatory response on four different occasions, by loosening the tension in the genital area and relaxing the anal sphincter not stop masturbating 4. Practice the ability to delay ejaculation as in previous exercises, but this time performing hip movements similar to penetration not stop masturbating
Sponsors & Collaborators
-
Universidad Miguel Hernandez de Elche
collaborator OTHER -
Instituto Sexológico Murciano
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-01
- Primary Completion
- 2017-10-30
- Completion
- 2017-12-01
Countries
- Spain
Study Locations
More Related Trials
-
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)
NCT02232425 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Intravaginal Ejaculation Time in Men With and Without Premature Ejaculation
NCT00210678 ·Status: COMPLETED
-
IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)
NCT03055806 ·Status: COMPLETED ·Phase: PHASE2
-
A Study On Concentrations Of 16448 In Blood And The Safety Of This Compound In Healthy Males With Premature Ejaculation
NCT00537459 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature Ejaculation
NCT01024491 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Study in Men With Premature Ejaculation
NCT01021553 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
NCT00211094 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation
NCT00219635 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PSD502 in Subjects With Premature Ejaculation
NCT03578783 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
NCT00229073 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment Of Safety Of UK-390,957
NCT00219609 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation
NCT00219583 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Low-Intensity Extracorporeal Shockwave Therapy and Vacuum Erectile Device as a Treatment for Peyronies Disease.
NCT03530540 ·Status: UNKNOWN ·Phase: NA
-
Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation
NCT07047404 ·Status: RECRUITING ·Phase: PHASE2
-
Exploratory Study of Pagoclone in Men With Premature Ejaculation.
NCT00370981 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.
NCT00211107 ·Status: COMPLETED ·Phase: PHASE3
-
Pilot Study of the Treatment of Erectile Dysfunction (ED) With Extracorporeal Shockwave Therapy (ESWT)
NCT02068417 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
NCT00556478 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation
NCT00210704 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Efficacy and Safety in Males Subjects With Premature Ejaculation
NCT00983151 ·Status: TERMINATED ·Phase: PHASE3
-
Low-Intensity Extracorporeal Shock Wave Treatment for Erectile Dysfunction: A Randomized, Controlled, Double Blind Trial
NCT03006536 ·Status: COMPLETED ·Phase: NA
-
Efficacy & Safety of Single Dose Alprostadil Cream (2 Concentrations Enhancer) to Vehicle in Men w/Erectile Dysfunction
NCT01810575 ·Status: TERMINATED ·Phase: PHASE2
-
Precise Use of Lidocaine Cream to Treat Primary Premature Ejaculation
NCT05749614 ·Status: UNKNOWN ·Phase: NA
-
Dornier Aries 2 Extracorporeal Shock Wave Device for the Treatment of Mild Erectile Dysfunction (ED)
NCT03039218 ·Status: TERMINATED ·Phase: NA
-
Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy
NCT07057011 ·Status: NOT_YET_RECRUITING ·Phase: NA